Besides mesenchymal stem cells being explored in the fight against pneumonia induced by COVID-19, there are numerous other current applications of MSCs in clinical trials. Mesenchymal stem cells are a choice candidate in studies targeting degenerative conditions for their ability to restore skeletal tissue and to differentiate into other cell types. Let’s take a brief look at the most current applications of mesenchymal stem cells being used in clinical trials.